2 ms·
Pfizer only submitted the data package on Nov 20th, with a review on Dec 10th. That's 20 days to review what is likely hundreds of pages of data, if not thousa
by refurb 6y ago
Pfizer only submitted the data package on Nov 20th, with a review on Dec 10th. That's 20 days to review what is likely hundreds of pages of data, if not thousands. It will be reviewed by hundreds of people, all with different expertise, who will need to talk to each other, dig into the data, re-run analyses, etc. You certainly don't want to just take the drug manufacturers word that everything checks out.
Plus, how the FDA approves it (including the speed) will create an impression on people's minds of how safe the vaccine is. Fast is good. "Too fast" is bad.
- modeless 6y agoPfizer had FDA Fast Track approval in July which means they could start reviewing it early as the trial progressed. In a sensible process all those hundreds of people should have reviewed and discussed nearly everything but the final numbers prior to Nov. 20 and been ready to plug in the numbers as soon as they came out.